Literature DB >> 19141133

National surgical patterns of care for primary surgery and axillary staging of phyllodes tumors.

Norleena Poynter Gullett1, Monica Rizzo, Peter A S Johnstone.   

Abstract

Phyllodes tumors (PT) are rare and unique in their suspected stromal and epithelial origin, and their propensity to recur despite surgical resection. Current surgical treatment of PT does not include sampling of regional lymph nodes (LNs) as malignant PT infrequently spread to LNs. We hypothesize that, because of substantial experience with common epithelial lesions of the breast, surgeons are more prone to sample LNs in PT patients. We reviewed national surgical patterns of care of axillary LN sampling for PT using the Surveillance Epidemiology &amp; End Results (SEER) registry. SEER data for LN evaluation are available from 1988. The public-access SEER data-base was queried for patients presenting over all 17 registries between 1988 and 2003 with PT of the breast. Data were collated by type of surgery and number of LNs examined, and further analyzed by tumor size of the primary lesion where available; 1,035 cases of PT were identified for the 16-year period. Patients had a median age of 50 (range 12-96). Of the specimens with SEER grade listed, 117 were well-differentiated, 186 moderately differentiated, 79 poorly differentiated, and 132 undifferentiated; 612 (59.1%) cases had specific surgical procedures reported: 191 partial, 251 simple, 5 subcutaneous, 154 modified radical, and 6 radical mastectomies, with 5 mastectomies (NOS) documented. The remainder of cases had surgery that was coded as "undocumented" or unknown. When surveyed by LNs examined, 25.5% of patients (n=264) underwent some degree of regional lymphadenectomy; the median number of LNs examined in these patients was 7 (range 1-37). Of all PT patients, 9.0% of patients underwent axillary sampling of 10 LN or more. Only nine patients (3.4%) had positive LNs. When assessing axillary sampling rate by tumor size, smaller lesions were less likely to undergo sampling than larger lesions (19.3% for lesions <2 cm, 20.5% for lesions 2-4.9 cm, 27.9% for 5-9.9 cm); although this was nonsignificant. In spite of the lack of supporting data for LN examination axillary staging continues to be performed for many cases of PT.

Entities:  

Mesh:

Year:  2009        PMID: 19141133     DOI: 10.1111/j.1524-4741.2008.00669.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  10 in total

1.  An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma in situ Within Fibroadenoma.

Authors:  Ashley Marumoto; Susan Steinemann; Nancy Furumoto; Stacey Woodruff
Journal:  Hawaii J Med Public Health       Date:  2019-02

2.  A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

Authors:  Juliana Giacomazzi; Patricia Koehler-Santos; Edenir Inez Palmero; Marcia S Graudenz; Luis Fernando Rivero; Eduardo Lima; Antonio Carlos Kruel Pütten; Pierre Hainaut; Suzi Alves Camey; Rodrigo Depieri Michelli; Cristovam Scapulatempo Neto; Mariana Fitarelli-Kiehl; Geraldo Geyer; Luise Meurer; Ana Geiger; Monica Blaya Azevedo; Vinicius Duval da Silva; Patricia Ashton-Prolla
Journal:  Virchows Arch       Date:  2013-06-21       Impact factor: 4.064

3.  A huge malignant phyllodes tumor of the breast with osteoclast-like giant cells: a case report.

Authors:  Taiyuan Liu; Lili Jiang; Jiasi Li; Jie Sun; Haomeng Li; Jiyue Gao; Sushan Li; Jun Li; Haidong Zhao
Journal:  Gland Surg       Date:  2021-04

4.  Fatal outcome of malignant phyllodes tumor of the breast in pregnancy: a case and literature review.

Authors:  Wen-Xiang Zhang; Xiang-Yi Kong; Jie Zhai; Yi Fang; Yan Song; Jing Wang
Journal:  Gland Surg       Date:  2021-01

5.  Diagnostic difficulties in giant benign phyllodes tumor.

Authors:  Ramona Andreea Matei; Mihai Mehedinţu-Ionescu; Ştefan Paitici; Eugen Florin Georgescu; Andreas Donoiu; Adina Mariana Ghemigian; Mihaela Popescu; Bogdan Dan Totolici; Carmen Neamţu; Stelian Ştefăniţă Mogoantă
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

6.  Malignant phyllodes tumors of the breast: a study in clinical practice.

Authors:  James Majeski; Jason Stroud
Journal:  Int Surg       Date:  2012 Apr-Jun

7.  Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines.

Authors:  Laura H Rosenberger; Samantha M Thomas; Suniti N Nimbkar; Tina J Hieken; Kandice K Ludwig; Lisa K Jacobs; Megan E Miller; Kristalyn K Gallagher; Jasmine Wong; Heather B Neuman; Jennifer Tseng; Taryn E Hassinger; Tari A King; James W Jakub
Journal:  J Clin Oncol       Date:  2020-12-10       Impact factor: 44.544

8.  A Case of Phyllodes Tumor of the Breast with Mixed Liposarcoma: Case Report and Literature Review.

Authors:  Mei Er Tu He Ta Mi Shi; Ning Wang; Qing Yao; Shuang-Shuang Dong; Xiao Feng; Jin Zhao; Hong Zou; Li-Juan Pang; Yan Qi
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

9.  Primary pleomorphic rhabdomyosarcoma of breast: Report of a rare neoplasm.

Authors:  Santosh Kumar Mondal; Palash Kumar Mandal; Anindya Adhikari; Bijan Basak
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

10.  Malignant phyllodes tumor with synchronous metastases to axillary lymph nodes, lung at the presentation: a case report and literature review.

Authors:  Quang Hong Le; Vuong The Mai
Journal:  J Surg Case Rep       Date:  2021-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.